(R)-1-(3-Chloro-4-fluorophenyl)ethanamine hydrochloride is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a crucial role in the development of chiral compounds, particularly in the production of drugs targeting central nervous system disorders. Its enantiomeric purity is essential for ensuring the efficacy and safety of the final drug product. Additionally, this compound is employed in research settings for studying receptor interactions and developing novel therapeutic agents with improved selectivity and reduced side effects.